Results 61 to 70 of about 919 (150)

Muscle Dysfunction and Bone Loss in a Woman With Cystic Fibrosis and Obesity Treated With Glucagon‐Like Peptide 1 Agonist: A Case Report

Respirology Case Reports, Volume 14, Issue 3, March 2026.
Cystic fibrosis (CF) modulator therapies can lead to rapid and excessive weight gain. Obesity in CF can lead to undesirable metabolic complications including type 2 diabetes. Therefore, glucagon‐like peptide 1 (GLP‐1) agonists which can facilitate weight loss and improve metabolic profiles are increasingly prescribed to people with CF.
Shanal Kumar, Robyn Cobb, Angela Matson, Joseph Lee, Daniel Henderson   +4 more
wiley   +1 more source

Vaginal‐Derived Potential Probiotics and Their Postbiotics Alleviate Aerobic Vaginitis via Suppressing TLR4/MyD88/NF‐κB Signalling Pathway and Potentially Enhancing Vaginal Barrier

Microbial Biotechnology, Volume 19, Issue 3, March 2026.
Consolidated diagram of the mechanism by which L. crispatus YBR‐01, L. plantarum YBR‐01, and their postbiotics improve AV progression. ABSTRACT Antibiotic therapy is currently challenged by drug resistance and high recurrence in aerobic vaginitis (AV), making it urgent to seek novel strategies. In this study, we selected two potential probiotic strains
Meiyun Tian, Xinyi Zhang, Xuan Xu, Xia He, Xiaoyun Wu, Jing Wei, Buzhen Tan, Tingtao Chen   +7 more
wiley   +1 more source

A forgotten pleasure: A unique case report of a neglected foreign body in a postmenopausal woman with persistent vaginal discharge [PDF]

Malaysian Family Physician
Recurrent vaginal discharge is a significant health issue for women globally, often leading to discomfort and a reduced quality of life. While normal vaginal discharge helps maintain vaginal health, changes in its composition can signal underlying ...
Muhammad Amir Nazri, Wan Mohd Nazlee Wan Zainon, Shaiful Bahari Ismail   +2 more
doaj   +1 more source

Research Progress in the Treatment of Vaginitis With Bioactive Compounds: Targeting of Vaginal Microflora

MicrobiologyOpen, Volume 15, Issue 1, February 2026.
Mechanism diagram of the effect of herbal medicine on vaginitis. Herbal medicines mainly combat vaginitis by (A) inhibiting bacteria, (B) inhibiting fungi, (C) acting on the cilia of Trichomonas, (D) inhibiting virus replication, (E) repairing the mucosa, (F) enhancing immunity, and (G) maintaining the microecological balance.
Yongming Li, Huiyu Liu, Ruihan Li, Rong Li, Jiaqi Liu   +4 more
wiley   +1 more source

Probiotic‐Based Materials as Living Therapeutics

Advanced Materials, Volume 38, Issue 1, 2 January 2026.
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio, Graham J. Day, Manuel Salmeron‐Sanchez   +2 more
wiley   +1 more source

Oral versus topical maintenance antifungal therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis

BMC Women's Health
Background Recurrent vulvovaginal candidiasis is a substantial personal and healthcare burden. This systematic review assessed the effects of topical versus oral maintenance antifungal therapy in women with recurrent vulvovaginal candidiasis to improve ...
Sara Ibrahim Abdelkader, Sally Aboelthana Aboelenin, Rahma Alaa Abdelhafez, Ashraf Fawzy Nabhan   +3 more
doaj   +1 more source

Antifungal Nanoparticles in Microbial Biotechnology: Multisector Mechanisms, Applications, and Future Frontiers

IET Nanobiotechnology, Volume 2026, Issue 1, 2026.
Fungal pathogens threaten global food security, ecosystem stability, and human health, while the overuse of conventional fungicides accelerates resistance and disrupts beneficial microbiota. Nanotechnology offers a powerful new paradigm for fungal control, but its greatest potential lies at the interface with microbial biotechnology.
Kaveh Rahimi Mamaghani, Marzieh Alikarami, Hossein Saremi, Nader Parvin, Jing Tu   +4 more
wiley   +1 more source

Attending to Gyn‐Ecology: Managing the ‘Mess’ of Recurrent Vulvovaginal Thrush

Sociology of Health &Illness, Volume 48, Issue 1, January 2026.
ABSTRACT Previous social science research on gendered experiences of thrush and vulvovaginal health has overlooked, or inadvertently sanitised, the materiality of having a body. Therefore, this study aims to return attention to the material, sensorial, and corporeal dimensions of living with recurrent thrush and use this to broaden our understandings ...
Tori Ford, Sue Ziebland, Sarah Tonkin‐Crine, Gail Hayward, Abigail McNiven   +4 more
wiley   +1 more source

Evaluation of the Efficacy of Acarbose on Ovarian Microbiota Profile, Ovary–Gut Axis, and SAP (1–10) Gene Expression in Rats Administered With Candida albicans Exosomes

Cellular Microbiology, Volume 2026, Issue 1, 2026.
Candida albicans is a commensal fungus of the vaginal and reproductive tract microbiota, but its overgrowth contributes to mucosal infections and reproductive dysfunctions. The fungus secretes exosomes carrying virulence factors, including secreted aspartyl proteinase (SAP) genes, which are critical for tissue invasion and immune modulation.
Bulent Dabanlioglu, Demet Celebi, Ozgur Celebi, Sumeyye Baser, Mustafa Can Guler, Ayhan Tanyeli, Betul Ari, Sıla Ektas Kalayci, Mesud Fakirullahoglu, Metin Kiliclioglu, Serkan Yildirim, Selahattin Celebi, Suraiya Saleem   +12 more
wiley   +1 more source

Vaginal azoles versus oral fluconazole in treatment of recurrent vulvovaginal candidiasis [PDF]

Background: Vulvovaginal candidiasis (VVC) is a fungal infection of the vagina and vulva. It is usually caused by Candida albicans, however, occasionally other candida species are responsible. The optimal treatment of VVC has not yet been defined.
فردی آذر, زهرا, عبدالهی فرد, صدیقه, تلو, مهشید, حبیب زاده, شهرام   +3 more
core